204 related articles for article (PubMed ID: 37139869)
21. Munc13-4 is a GTP-Rab27-binding protein regulating dense core granule secretion in platelets.
Shirakawa R; Higashi T; Tabuchi A; Yoshioka A; Nishioka H; Fukuda M; Kita T; Horiuchi H
J Biol Chem; 2004 Mar; 279(11):10730-7. PubMed ID: 14699162
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac, Cdc42, and Rho GTPases.
Dunford JE; Rogers MJ; Ebetino FH; Phipps RJ; Coxon FP
J Bone Miner Res; 2006 May; 21(5):684-94. PubMed ID: 16734383
[TBL] [Abstract][Full Text] [Related]
23. Atorvastatin Targets the Islet Mevalonate Pathway to Dysregulate mTOR Signaling and Reduce β-Cell Functional Mass.
Shen L; Gu Y; Qiu Y; Cheng T; Nie A; Cui C; Fu C; Li T; Li X; Fu L; Wang Y; Ni Q; Wang Q; Wang W; Feng B
Diabetes; 2020 Jan; 69(1):48-59. PubMed ID: 31649162
[TBL] [Abstract][Full Text] [Related]
24. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
Taylor FB; Müller-Eberhard HJ
J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
[TBL] [Abstract][Full Text] [Related]
25. Effects of lovastatin on Rho isoform expression, activity, and association with guanine nucleotide dissociation inhibitors.
Turner SJ; Zhuang S; Zhang T; Boss GR; Pilz RB
Biochem Pharmacol; 2008 Jan; 75(2):405-13. PubMed ID: 17920041
[TBL] [Abstract][Full Text] [Related]
26. A role for Rab27b in NF-E2-dependent pathways of platelet formation.
Tiwari S; Italiano JE; Barral DC; Mules EH; Novak EK; Swank RT; Seabra MC; Shivdasani RA
Blood; 2003 Dec; 102(12):3970-9. PubMed ID: 12907454
[TBL] [Abstract][Full Text] [Related]
27. 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture.
Guijarro C; Blanco-Colio LM; Ortego M; Alonso C; Ortiz A; Plaza JJ; Díaz C; Hernández G; Egido J
Circ Res; 1998 Sep; 83(5):490-500. PubMed ID: 9734471
[TBL] [Abstract][Full Text] [Related]
28. Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin.
Dunn SE; Youssef S; Goldstein MJ; Prod'homme T; Weber MS; Zamvil SS; Steinman L
J Exp Med; 2006 Feb; 203(2):401-12. PubMed ID: 16476765
[TBL] [Abstract][Full Text] [Related]
29. Atorvastatin acutely reduces the reactivity to spasmogens in rat aorta: implication of the inhibition of geranylgeranylation and MYPT-1 phosphorylation.
Alp Yildirim Fİ; Kaleli Durman D; Aypar E; Ark M; Özdemir O; Uydeş Doğan BS
Fundam Clin Pharmacol; 2016 Apr; 30(2):96-106. PubMed ID: 26610064
[TBL] [Abstract][Full Text] [Related]
30. ClfA(221-550), a fibrinogen-binding segment of Staphylococcus aureus clumping factor A, disrupts fibrinogen function.
Liu CZ; Shih MH; Tsai PJ
Thromb Haemost; 2005 Aug; 94(2):286-94. PubMed ID: 16113817
[TBL] [Abstract][Full Text] [Related]
31. Reversal of thrombin-induced deactivation of CD39/ATPDase in endothelial cells by HMG-CoA reductase inhibition: effects on Rho-GTPase and adenosine nucleotide metabolism.
Kaneider NC; Egger P; Dunzendorfer S; Noris P; Balduini CL; Gritti D; Ricevuti G; Wiedermann CJ
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):894-900. PubMed ID: 12067895
[TBL] [Abstract][Full Text] [Related]
32. A novel statin-mediated "prenylation block-and-release" assay provides insight into the membrane targeting mechanisms of small GTPases.
Ali BR; Nouvel I; Leung KF; Hume AN; Seabra MC
Biochem Biophys Res Commun; 2010 Jun; 397(1):34-41. PubMed ID: 20471365
[TBL] [Abstract][Full Text] [Related]
33. Human platelets express organic anion-transporting peptide 2B1, an uptake transporter for atorvastatin.
Niessen J; Jedlitschky G; Grube M; Bien S; Schwertz H; Ohtsuki S; Kawakami H; Kamiie J; Oswald S; Starke K; Strobel U; Siegmund W; Rosskopf D; Greinacher A; Terasaki T; Kroemer HK
Drug Metab Dispos; 2009 May; 37(5):1129-37. PubMed ID: 19237515
[TBL] [Abstract][Full Text] [Related]
34. Atorvastatin Inhibited ROS Generation and Increased IL-1β And IL-6 Release by Mononuclear Cells from Diabetic Patients.
Dos Anjos PMF; Volpe CMO; Miranda TC; Nogueira-Machado JA
Endocr Metab Immune Disord Drug Targets; 2019; 19(8):1207-1215. PubMed ID: 31416412
[TBL] [Abstract][Full Text] [Related]
35. Differences in the Phosphorylation-Dependent Regulation of Prenylation of Rap1A and Rap1B.
Wilson JM; Prokop JW; Lorimer E; Ntantie E; Williams CL
J Mol Biol; 2016 Dec; 428(24 Pt B):4929-4945. PubMed ID: 27760305
[TBL] [Abstract][Full Text] [Related]
36. Abrogation of insulin-like growth factor-I (IGF-I) and insulin action by mevalonic acid depletion: synergy between protein prenylation and receptor glycosylation pathways.
Siddals KW; Marshman E; Westwood M; Gibson JM
J Biol Chem; 2004 Sep; 279(37):38353-9. PubMed ID: 15247258
[TBL] [Abstract][Full Text] [Related]
37. Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure.
Misztal T; Rusak T; Brańska-Januszewska J; Ostrowska H; Tomasiak M
Free Radic Biol Med; 2015 Dec; 89():533-47. PubMed ID: 26454084
[TBL] [Abstract][Full Text] [Related]
38. Statins Promote Interleukin-1β-Dependent Adipocyte Insulin Resistance Through Lower Prenylation, Not Cholesterol.
Henriksbo BD; Tamrakar AK; Xu J; Duggan BM; Cavallari JF; Phulka J; Stampfli MR; Ashkar AA; Schertzer JD
Diabetes; 2019 Jul; 68(7):1441-1448. PubMed ID: 31010959
[TBL] [Abstract][Full Text] [Related]
39. Lovastatin and perillyl alcohol inhibit glioma cell invasion, migration, and proliferation--impact of Ras-/Rho-prenylation.
Afshordel S; Kern B; Clasohm J; König H; Priester M; Weissenberger J; Kögel D; Eckert GP
Pharmacol Res; 2015 Jan; 91():69-77. PubMed ID: 25497898
[TBL] [Abstract][Full Text] [Related]
40. Statins reduce amyloid-beta production through inhibition of protein isoprenylation.
Ostrowski SM; Wilkinson BL; Golde TE; Landreth G
J Biol Chem; 2007 Sep; 282(37):26832-26844. PubMed ID: 17646164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
